Company Overview
| Stock Name | Sipai Health |
| Stock Code | 00314 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事特藥藥房業務、醫生研究協助業務及健康保險服務業務。 |
| Listing Date | 2022-12-23 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省廣州市廣州國際生物島螺旋大道51號官洲生命科學創新中心A塔26樓11–13室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.medbankshealthtech.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism |
To be extracted
|
| Offer Price | HK$ 18.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 18,451,200 |
Stock Connect Inclusion
| 26Q2 Regular Review |
| Inclusion Pathway |
None |
| Est. Threshold |
--- |
| Analysis Result |
无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 25.0 |
| First Day Open | HK$ 23.7 |
| First Day Change | 34.41% |
| First Day Volume | 2174600.0 |
| First Day Turnover | 52611300.0 |
Use of Proceeds
| Use of Proceeds | 1、約87%或約104.8百萬港元預計將用于業務擴張;
2、約13%或約15.6百萬港元預期將用于技術研發及提升技術基礎設施。 |
Underwriting Syndicate
Overall Coordinators (2)
Morgan Stanley Asia Limited CE AAD291
HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806
Joint Bookrunners (2)
Morgan Stanley Asia Limited CE AAD291
HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 馬旭廣 |
| Company Secretary | 任娜 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 騰訊控股有限公司(27.41%);FMR LLC(9.09%);馬旭廣(7.47%);Ching Hsin Chang Jimmy(6.96%),方舟信托(香港)有限公司(5.30%);李繼(5.24%) |
// About this page //
This page shows Sipai Health (00314) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements.
Disclaimer
Site Nature: This website (cibo.hk) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.